BOCA RATON, Fla., July 15, 2013 /PRNewswire/ -- Sensus Healthcare is pleased to announce Dr. Clay Cockerell as Medical Director. Dr. Cockerell will lead the distinguished members of the Medical Advisory Board as the Company continues to provide technology for non-invasive skin cancer treatment for NMSC as well as treatment for keloid scars.
Dr. Cockerell said, "I am excited to be involved with Sensus and for the opportunity to see the ongoing development of dermatologic radiotherapy. This is an excellent technique that provides a very good supplement in select patients to the excellent dermatologic surgical techniques, including Mohs Surgery, that we routinely employ."
"We are extremely honored to have such a respected and distinguished advocate join our Team," stated Joe Sardano, President/CEO of Sensus Healthcare.
Dr. Cockerell is a practicing dermatologist and dermatopathologist in Dallas, Texas. He is Director of Cockerell and Associates Dermpath Diagnostics Laboratories, Clinical Professor of Dermatology and Pathology and Director of Dermatopathology at the University of Texas Southwestern Medical Center.
Dr. Cockerell received his MD degree from Baylor College of Medicine in 1981. He has authored over 500 publications and has been responsible for training over 40 Dermatopathology fellows since 1988. He has lectured extensively across the United States and around the world.
Dr. Cockerell has served the American Academy of Dermatology (AAD) as President (2005), Secretary-Treasurer (2001-2004); Board of Directors (1998-2004); Executive Committee (1998-2004); Assistant Secretary-Treasurer (1998-2001) and on various other committees. He was President of the Texas Dermatological Society (2003-2004).
He has served on the editorial board of numerous journals including Assistant Editor for Journal of the American Academy of Dermatology (1993-1998). He is active with the American Academy of HIV Medicine, American College of Physician Executives, American Medical Association, American Society of Clinical Pathologists, American Society of Dermatology, College of American Pathologists, Dallas County Medical Society, International Academy of Pathology, International AIDS Society, International Society of Dermatology, Louisiana Dermatology Society, Masters Dermatologic Association, North American Clinical Dermatologic Society, Sir James Saunders Society, South Central Dermatology Society, Southwestern Dermatology Association, Texas Medical Association, Texas Society of Pathologists, United States and Canadian Academy of Pathology.
About Sensus Healthcare:
Sensus Healthcare is a medical device company aimed at treating non-melanoma skin cancer and keloid scars with superficial radiation therapy (SRT). Our SRT systems automate and complement surgical procedures in order to provide both excellent therapeutic and cosmetic results. Our mobile, compact SRT-100™ systems are used throughout the world by leading radiation oncologists, plastic surgeons, general surgeons, and dermatologists to bring non-melanoma skin cancer and keloid treatments to more patients in more settings.
561-922-5808 Ext. *100
|SOURCE Sensus Healthcare|
Copyright©2012 PR Newswire.
All rights reserved